Verastem (VSTM) Return on Invested Capital (2024 - 2025)

Verastem (VSTM) recorded quarterly Return on Invested Capital of 0.16% in Q3 2025, up 81.94% quarter-over-quarter from 0.87% in Q2 2025.

Verastem (VSTM) Return on Invested Capital (2024 - 2025) Analysis & Trends

Verastem's Return on Invested Capital history runs 2 years deep, the most recent figure standing at 0.16% for Q3 2025.

In Q3 2025, Return on Invested Capital changed N/A year-over-year to 0.16%; the TTM figure through Sep 2025 stood at 0.16% (changed N/A YoY), while the FY2024 annual figure was 0.08%, changed N/A from the prior year.
Return on Invested Capital was 0.16% for Q3 2025 at Verastem, up from 0.87% in the prior quarter.
In the past five years, Return on Invested Capital ranged from a high of 0.29% in Q4 2024 to a low of 0.87% in Q2 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	ROIC (Qtr)
1	Alterity Therapeutics	925,601.88 Bn	925,601.85 Bn	-	-
2	Belite Bio	58,560.00 Bn	58,560.00 Bn	-	-
3	Quantum Biopharma	17,284.41 Bn	17,284.40 Bn	-	-
4	Legend Biotech	2,809.00 Bn	2,808.71 Bn	242.10 Mn	0.01%
5	Evaxion A	1,334.43 Bn	1,334.42 Bn	-	-0.01%
6	Akari Therapeutics	1,312.27 Bn	1,312.26 Bn	-	-0.01%
7	Psyence Biomedical	212.16 Bn	212.16 Bn	-	-
8	Vertex Pharmaceuticals	114.83 Bn	107.58 Bn	2.59 Bn	0.00%
9	Abivax	91.96 Bn	91.96 Bn	-	-
10	Verastem	407.42 Mn	225.74 Mn	15.90 Mn	-

Download Data